Business Description
Diasorin SpA
NAICS : 325413
ISIN : IT0003492391
Share Class Description:
STU:34D: Ordinary SharesCompare
Compare
Traded in other countries / regions
DIA.Italy0GZX.UK34D.GermanyDIAS.AustriaDSRLF.USA IPO Date
2007-07-23Description
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | 4.25 | |||||
| Interest Coverage | 12.82 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.8 | |||||
| 3-Year EBITDA Growth Rate | -2 | |||||
| 3-Year EPS without NRI Growth Rate | -11.7 | |||||
| 3-Year FCF Growth Rate | -5.2 | |||||
| 3-Year Book Growth Rate | 18.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 14.14 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 6.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.27 | |||||
| 9-Day RSI | 48.69 | |||||
| 14-Day RSI | 48.8 | |||||
| 6-1 Month Momentum % | 10.67 | |||||
| 12-1 Month Momentum % | 11.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.12 | |||||
| Quick Ratio | 1.89 | |||||
| Cash Ratio | 0.81 | |||||
| Days Inventory | 286.8 | |||||
| Days Sales Outstanding | 61.9 | |||||
| Days Payable | 88.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.15 | |||||
| Dividend Payout Ratio | 0.34 | |||||
| 3-Year Dividend Growth Rate | 5 | |||||
| Forward Dividend Yield % | 1.15 | |||||
| 5-Year Yield-on-Cost % | 1.49 | |||||
| 3-Year Average Share Buyback Ratio | 0.9 | |||||
| Shareholder Yield % | 5.69 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.76 | |||||
| Operating Margin % | 21.16 | |||||
| Net Margin % | 14.54 | |||||
| FCF Margin % | 27.6 | |||||
| ROE % | 10.79 | |||||
| ROA % | 5.89 | |||||
| ROIC % | 7.47 | |||||
| 3-Year ROIIC % | -3.41 | |||||
| ROC (Joel Greenblatt) % | 57.5 | |||||
| ROCE % | 9.07 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.48 | |||||
| Forward PE Ratio | 24.58 | |||||
| PE Ratio without NRI | 29.78 | |||||
| Shiller PE Ratio | 26.72 | |||||
| PEG Ratio | 2.73 | |||||
| PS Ratio | 4.58 | |||||
| PB Ratio | 3.29 | |||||
| Price-to-Free-Cash-Flow | 16.58 | |||||
| Price-to-Operating-Cash-Flow | 16.58 | |||||
| EV-to-EBIT | 25.7 | |||||
| EV-to-Forward-EBIT | 20.44 | |||||
| EV-to-EBITDA | 25.7 | |||||
| EV-to-Forward-EBITDA | 14.56 | |||||
| EV-to-Revenue | 5.35 | |||||
| EV-to-Forward-Revenue | 4.84 | |||||
| EV-to-FCF | 19.11 | |||||
| Price-to-Projected-FCF | 0.93 | |||||
| Price-to-DCF (Earnings Based) | 1.47 | |||||
| Price-to-DCF (FCF Based) | 0.8 | |||||
| Price-to-Median-PS-Value | 0.77 | |||||
| Earnings Yield (Greenblatt) % | 3.89 | |||||
| FCF Yield % | 5.93 | |||||
| Forward Rate of Return (Yacktman) % | 9.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Diasorin SpA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,161.416 | ||
| EPS (TTM) (€) | 3.166 | ||
| Beta | 1.08 | ||
| Volatility % | 21.69 | ||
| 14-Day RSI | 48.8 | ||
| 14-Day ATR (€) | 2.318015 | ||
| 20-Day SMA (€) | 101.7215 | ||
| 12-1 Month Momentum % | 11.9 | ||
| 52-Week Range (€) | 81.36 - 105.9 | ||
| Shares Outstanding (Mil) | 53.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Diasorin SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Diasorin SpA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Diasorin SpA Frequently Asked Questions
What is Diasorin SpA(STU:34D)'s stock price today?
The current price of STU:34D is €101.10. The 52 week high of STU:34D is €105.90 and 52 week low is €81.36.
When is next earnings date of Diasorin SpA(STU:34D)?
The next earnings date of Diasorin SpA(STU:34D) is 2024-11-15.
Does Diasorin SpA(STU:34D) pay dividends? If so, how much?
The Dividend Yield %  of Diasorin SpA(STU:34D) is 1.15% (As of Today), Highest Dividend Payout Ratio of Diasorin SpA(STU:34D) was 0.35. The lowest was 0.18. And the median was 0.3. The  Forward Dividend Yield % of Diasorin SpA(STU:34D) is 1.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers